KathleenElizabethCoreyMD
Gastroenterology • Boston, MAHepatology & Liver Transplantation
Instructor in Medicine, Massachusetts General Hospital
Dr. Corey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Nicolls Rd
Boston, MA 11794Phone+1 617-724-6113Fax+1 617-724-5997
Education & Training
Massachusetts General HospitalResidency, Internal Medicine, 2003 - 2006
Duke University School of MedicineClass of 2003- Massachusetts General HospitalFellowship, Interventional Cardiology
Certifications & Licensure
MA State Medical License 2005 - 2025- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Evaluating the Efficacy of CPAP Therapy for the Treatment of Fatty Liver Start of enrollment: 2019 Mar 01
- Impact of Weight Loss Surgery in Adolescents With NAFLD Start of enrollment: 2014 Sep 15
Publications & Presentations
PubMed
- 61 citationsCost-effectiveness of Bariatric Surgery in Adolescents With ObesityMatthew J. Klebanoff, Jagpreet Chhatwal, Jacob D. Nudel, Kathleen E. Corey, Lee M. Kaplan
JAMA Surgery. 2017-02-01 - 68 citationsAssociation of Genetic Variation With Cirrhosis: A Multi-Trait Genome-Wide Association and Gene-Environment Interaction StudyConnor A. Emdin, Mary E. Haas, Veeral Ajmera, Tracey G. Simon, Julian R. Homburger
Gastroenterology. 2021-04-01 - 98 citationsDimethylguanidino valeric acid is a marker of liver fat and predicts diabetesJohn F. O'Sullivan, Jordan Morningstar, Qiong Yang, Baohui Zheng, Yan Gao
The Journal of Clinical Investigation. 2017-10-30
Journal Articles
- The Great Opportunity: Cultivating Scientific Inquiry in Medical ResidencyMarc N Wein, Michael K Mansour, Jatin M Vyas, Jayaraj Rajagopal, Mark C Fishman, Kathleen E Corey, Caroline L Sokol, Katrina A Armstrong, The Journal of Infectious Diseases
- Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in HIV/HCV CoinfectionMa Somsouk, Eoin R Feeney, Raymond T Chung, Steven Deeks, Annie J Kruger, Ricard Masia, Kathleen E Corey, Esperance A Schaefer, The Journal of Infectious Diseases
Authored Content
- The Nonalcoholic Fatty Liver Disease (NAFLD) Fibrosis Score, Cardiovascular Risk Stratification and a Strategy for Secondary Prevention with EzetimibeMay 2018
Press Mentions
Fatty Liver Disease Symptoms Are Often ‘Silent’: MDs Explain What to Look ForJuly 24th, 2024- Fatty Liver Disease: Bleeding Gums Could Indicate Your Risk of the Deadly ConditionFebruary 26th, 2021
Machine Learning Used to Surpass MELD in Assessing Liver DiseaseOctober 26th, 2017- Join now to see all
Grant Support
- Interactions Between Hepatitis C And Serum Lipid HomeostasisNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2010
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
